AAO-HNS/F Network Search

Clarification on Reporting the Sinusectomy CPT Codes Q. When a surgeon suctions purulent mucoid material from any of the sinuses, is this considered removal of tissue and reported with codes 31254/31255, 31267, or 31288? Is it appropriate to report sinusectomy codes when the surgeon…

Q: Would insertion of an absorbable nasal implant, such as Latera®, to treat nasal obstruction from valve collapse be reported with CPT code 30465, Repair of nasal vestibular stenosis (eg, spreader grafting, lateral nasal wall reconstruction)? A: No.  This procedure should be reported with…

As AAO-HNS members are likely aware, 2018 brings significant changes to the Endoscopic Sinus Surgery (“FESS”) and Sinus Ostial Dilation (e.g., balloon sinus dilation or “BSD”) family of CPT codes. In January 2015, the FESS and BSD family of codes were captured in…

Download PDF High Priority Status: Yes / Appropriate Use NQF Number: N/A Measure Description: Percentage of patients diagnosed with Benign Positional Paroxysmal Vertigo (BPPV) who received vestibular testing, imaging, and antihistamine or benzodiazepine medications. Instructions: This measure is to be submitted a minimum of once…

Download PDF High Priority Status: Yes / Outcome CBE Number: N/A Measure Description: Percentage of patients aged 6 months and older with a diagnosis of otitis media with effusion (OME) who are seen 2 to 8 weeks after tympanostomy tube surgery and OME is resolved…

Download PDF High Priority Status: No / N/A CBE Number: N/A Measure Description: Percentage of patients aged 6 months through 12 years with a diagnosis of otitis media with effusion (OME) who received tympanostomy tube insertion and received a comprehensive audiometric evaluation within 6…

Download PDF High Priority Status: No / N/A CBE Number: N/A Measure Description: Percentage of patients aged 6 months to 12 years of age with a diagnosis of otitis media with effusion (OME) including chronic serous, mucoid, or nonsuppurative OME of ≥ 3 months duration…

Download PDF High Priority Status: Yes / Appropriate Use CBE Number: N/A Measure Description: Percentage of patients aged 6 months to 12 years of age at the time of the visit with a current diagnosis of an uncomplicated acute tympanostomy tube otorrhea (TTO) who were…

Download PDF High Priority Status: Yes / Appropriate Use CBE Number: N/A Measure Description: Percentage of patients aged 16 years and older with a new onset diagnosis of Bell’s palsy who had a magnetic resonance imaging (MRI), or a computed tomography (CT) scan of…

…

As members are likely aware, 2014 brought significant changes to the Esophagoscopy family of CPT codes. Specifically, the code set was revised to more clearly identify the types of endoscope and approach used when performing the procedure, as it was agreed that the physician work…

The Centralized Otolaryngology Research Efforts (CORE) grants program is a collaboration of several societies, foundations, and industry supporters focused on providing support for research in the field of otolaryngology-head and neck surgery. …

AAO-HNSF Bylaw Articles As amended by vote of the AAO-HNS Membership on June 4, 2020. Section 1.01. Registered Office  The American Academy of Otolaryngology—Head and Neck Surgery Foundation, Inc. (hereinafter referred to as the “Foundation”) shall have and continuously maintain…

Q: How can I report an endoscopic laryngoplasty? A: The Academy recommends the use of CPT code 31599- Unlisted code, larynx to report an endoscopic laryngoplasty. Physicians should not use CPT codes 31580, 31551, 31552, 31553, 31554, 31584, nor 31587 to report this procedure, as…

Q: How do I code for percutaneous laryngeal injections using flexible endoscopic guidance? A: Percutaneous laryngeal injections performed using flexible laryngoscopy for guidance and needle placement should be reported using 31574. This describes injection (s) for augmentation (eg percutaneous, transoral) for unilateral vocal cord. Q…

For CY 2013, the CPT Editorial Panel has modified the descriptor for add on code +15777 and has limited this code’s use to biologic implants placed into breast and/or trunk sites only. The new text is underlined below. The new descriptor and corresponding…